United States Sleep Apnea Devices Market Research Report Information By Diagnostic Devices (Polysomnography Devices (PSG), Pulse Oximeters, and Actigraphy Devices), By Therapeutic Devices (Positive Airway Pressure (PAP) Devices (Continuous Positive Airway Pressure (CPAP) Devices, Bi-level Positive Airway Pressure (BiPAP) Devices), Oxygen Devices (Oxygen Concentrators, Portable Oxygen Concentrators, Liquid Portable Oxygen), Oral Appliances, Adaptive Servo Ventilation (ASV) Devices, and Masks and Accessories), - United States Market Forecast

U.S. Sleep Apnea Devices Market Overview

United States Sleep Apnea Devices Market Size was valued at USD 1.6 Billion in 2022. The sleep apnea devices market industry is projected to grow from USD 1.704 Billion in 2023 to USD 2.820 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.50% during the forecast period (2024 - 2032). A growing number of people are becoming older, the high prevalence of sleep apnea, rising potential risk factors, and technological developments in sleep apnea devices are all contributing market drivers to the growing market for sleep apnea devices.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Sleep Apnea Devices Market Trends

Rising Disorders Related to Lifestyle will Boost the Market Growth

Large patient populations in industrialized and emerging nations need treatment or management of several lifestyle disorders, including obesity, which is becoming more common, and sleep apnea, which is becoming more often diagnosed. This is assisting in the market's expansion, along with the increase in sleep clinics and sleep techs. One in fifteen adults in the United States is thought to have obstructive sleep apnea (OSA), or 18 million people, according to research released by Sleep Science Resource, LLC. People who lead sedentary lives are more likely to suffer from obesity, poor sleep, elevated stress levels, and cardiovascular illnesses. As per the American Heart Association, Inc. article, multiple cross-sectional studies have approximated that 40% of the obese population has substantial sleep apnea, and 70% of OSA patients are obese. By launching programs like "Sleep Awareness Week," a number of organizations and governmental bodies are concentrating on raising patient awareness and diagnosis rates. Throughout the projected term, this is also expected to fuel market expansion.

According to a number of studies, patient adherence during the first few weeks of treatment is a major predictor of long-term CPAP compliance. During this time, there needs to be quick compliance, support, and follow-up. Since it is difficult to provide such support due to lengthy waiting lists, telemedicine provides this aid. Patients in the telemedicine group appeared to be very satisfied with their care, according to several studies. They found a live video session with a sleep doctor to be extremely convenient. Rather than duplicating traditional visits, mHealth can offer shorter and more frequent assessments; mobile applications with straightforward questionnaires may aid in follow-up, and alarm systems on patients' devices can notify doctors. Due to the potential advantages that telemedicine and mHealth may bring in terms of bettering the diagnosis and treatment of sleep apnea, the market for the condition is anticipated to expand. Thus, driving the sleep apnea devices market revenue.

Sleep Apnea Devices Market Segment Insights

Sleep Apnea Devices Diagnostic Devices Insights

The US Sleep Apnea Devices market segmentation, based on diagnostic devices, includes Polysomnography Devices (PSG), Pulse Oximeters, and Actigraphy Devices. The pulse oximeters segment dominated the market mostly. The measuring of blood hemoglobin oxygen saturation is a common use for pulse oximeters. They serve as a reasonably noninvasive means of continuously monitoring blood hemoglobin oxygen saturation throughout time. Owing to their ease of use, they have practically become a standard piece of equipment in medical facilities. Moreover, the category is anticipated to have growth throughout the projected period because of the rising prevalence of sleep apnea.

Figure 1: United States Sleep Apnea Devices Market, by Diagnostic Devices, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Sleep Apnea Devices Therapeutic Devices Insights

The US Sleep Apnea Devices market segmentation, based on therapeutic devices, includes Positive Airway Pressure (PAP) Devices (Continuous Positive Airway Pressure (CPAP) Devices, Bi-level Positive Airway Pressure (BiPAP) Devices), Oxygen Devices (Oxygen Concentrators, Portable Oxygen Concentrators, Liquid Portable Oxygen), Oral Appliances, Adaptive Servo Ventilation (ASV) Devices, and Masks and Accessories. The positive airway pressure (PAP) devices category generated the most income. One type of respiratory ventilation used to treat sleep apnea is the positive airway pressure device. It's also utilized for hospitalized patients, newborns, and people who have trouble breathing deeply. It also prevents and treats atelectasis in these patients. According to studies, 80% of individuals with obstructive sleep apnea who have been diagnosed choose to use PAP devices. This increased patient compliance rate, along with advantageous insurance coverage linked to adherence standards for PAP therapy, is encouraging broad adoption.

Sleep Apnea Devices Country Insights

The United States is one of the top regions in the adoption of technology connected to sleep disorders. The rising incidence of respiratory illnesses is pushing the market for certain sleeping disorders. Furthermore, a larger patient base, the presence of foreign producers, and rising awareness of sleep apnea are expected to contribute to this region's increased market share. Patients with sleep problems or other medical illnesses that can result in sleep disturbances are also driving growth by using sleep apnea devices more frequently. For instance, in 2014, over 25 million adults in the United States suffered from sleep apnea and other sleeping problems, according to the National Healthy Sleep Awareness Project. Moreover, the market for sleep apnea equipment is expanding in the US due in large part to rising disposable incomes and the widespread use of different respiratory devices. Moreover, the COVID-19 pandemic has led to an increased emphasis on technical advancements and telehealth, which has impacted the US market by offering chances for remote monitoring and consulting.

Sleep Apnea Devices Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the sleep apnea devices market grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the sleep apnea devices industry must offer cost-effective items.

Major players in the sleep apnea devices market are attempting to increase market demand by investing in research and development operations, including Fisher & Paykel Healthcare Limited, Invacare Corporation, Natus Medical Incorporated, Teleflex Incorporated, Vyaire Medical Inc., GE Healthcare, Nihon Kohden Corporation, Resmed, Cadwell Laboratories Inc., Koninklijke Philips NV, Somnomed, and Oventus Medical.

Key Companies in the sleep apnea devices market include

• Fisher & Paykel Healthcare Limited


• Invacare Corporation


• Natus Medical Incorporated


• Teleflex Incorporated


• Vyaire Medical Inc.


• GE Healthcare


• Nihon Kohden Corporation


• Resmed


• Cadwell Laboratories Inc.


• Koninklijke Philips NV


• Somnomed


• Oventus Medical

Sleep Apnea Devices Industry Developments

October 2022: The most extensively studied custom oral appliance maker in the world, Airway Management, recently announced the release of flexTAP, a high-end lab-made mouth appliance intended to treat individuals with mild to severe obstructive sleep apnea and snoring.

June 2021: Oventus Medical and Aeroflow Healthcare have partnered to provide direct patient access to Oventus' obstructive sleep apnea (OSA) treatment alternatives, including O2Vent Optima, via US sleep clinics.

February 2021: The first-ever daytime therapy for OSA, eXciteOSA, was approved by the USFDA for use as an intraoral neuromuscular stimulation device by Signifier Medical Technologies.

Sleep Apnea Devices Market Segmentation

Sleep Apnea Devices Diagnostic Devices Outlook

• Polysomnography Devices (PSG)


• Pulse Oximeters


• Actigraphy Devices

Sleep Apnea Devices Therapeutic Devices Outlook

• Positive Airway Pressure (PAP) Devices
  
  
  
  • Continuous Positive Airway Pressure (CPAP) Devices
  
  
  • Bi-level Positive Airway Pressure (BiPAP) Devices
  
  
  
  


• Oxygen Devices
  
  
  
  • Oxygen Concentrators
  
  
  • Portable Oxygen Concentrators
  
  
  • Liquid Portable Oxygen
  
  
  
  


• Oral Appliances


• Adaptive Servo Ventilation (ASV) Devices


• Masks and Accessories